Insulet Corporation develops insulin delivery systems for people with insulin-dependent diabetes. The companys Omnipod platform includes three products: Omnipod 5, Omnipod DASH, and Omnipod GO. Products are sold through distributors, pharmacies, and directly in various countries.
| Indicator | Value |
|---|---|
| PER | 49.0 |
| EV/EBITDA | 20.6 |
| Price/Free Cash Flow' | 34.6 |
| ROIC | 23.1% |
| Net Debt/EBITDA | 0.4 |